Contineum Therapeutics, Inc. (CTNM) Revenue 2023–2024
Contineum Therapeutics, Inc. (CTNM) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$0FY2024 · since FY2023: $50.0M → $0
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $0 | -100.0% |
| FY2023 | $50.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice